Kaiser Permanente Ventures
Venture Capital Corporate VC Est. 1998
USD 450M
Estimated FUM
- Type
- Venture Capital
- HQ
- Oakland, CA, United States
- Founded
- 1998
- Focus
- Healthtech / Life Sciences
About
Kaiser Permanente Ventures is a healthcare investor focused on Health IT, Digital Health, Healthcare Services, Medical Devices and Diagnostics and Precision Medicine. We work with Kaiser Permanente, our lead investor, along with our other limited partners.
Strategies
Venture Capital
Breadth not publicly established
Growth Equity
Breadth not publicly established
Investment Focus
Investment size
USD 500K - USD 10M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Focus Areas
Stages
Growth Series A Series B
Focus
Healthtech / Life Sciences
Specialist
Investment Geographies
Primary Markets
United States
Coverage
Country-focused Regions
North America
Coverage is a guide only.
Location
Headquarters
Oakland, CA, United States
Office Presence
1 country
United States
1 known office
Oakland, CA, United States (HQ)
Deals & Activity
Tracked Deals
25
Most common deal types
Unknown (25)
Deals by domain
Saas 1
Healthcare 1
Cpg 1
Recent tracked deals
leiters.com
Healthcare
kitcheck.com
Saas
www.katefarms.com
www.irhythmtech.com
www.intelycare.com
ingeniousmed.com
www.healthcatalyst.com
gynesonics.com
People also viewed
Foundry Group
Foundry Group is a Colorado-based venture firm that invests in early-stage and growth-stage companies headquartered in the US and Canada. Foundry Group also invests in select, newly-formed venture capital fund managers. Foundry Group formed in 2007 and originally focused on Seed and Series A investments. It raised a growth-stage fund in 2014 (Foundry Group Next), and a fund dedicated to investing in other venture funds (Foundry Group Next) in 2016.
Regardless of the size of our initial investment, the size and structure of our funds allow us to continue to fund portfolio companies through their entire financing lifecycles. In addition, our venture capital fund investments give us insight and access to a large number of venture-backed companies at varying stages while extending the reach of our overall network. In addition to providing capital, we leverage our experience in starting and growing companies, our expertise in the technology industry, and our network of relationships to help outstanding entrepreneurs and venture capital fund managers turn great ideas into great companies.
Venrock
Venrock is a venture capital firm headquartered in Palo Alto that focuses on disruptive early-stage technology startups. Venrock partners with entrepreneurs who have grand ambitions and want to tackle big, hard problems that most think impossible. Venrock today consists of two separate programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies.
Venrock was formed in 1969 as a venture arm of the Rockefeller family (the name Venrock being a compound of Venture and Rockefeller), who have a long history of venture-style investing dating back to the early 20th century.
Canaan Partners
Canaan Partners is an early-stage venture capital firm investing in technology and healthcare companies in the United States.
Edison Partners
Edison Partners is a growth-stage venture capital firm based in Princeton, NJ that invests in technology-enabled companies in the Eastern United States. Edison focuses its investments on three areas in which it has deep exertise: Fintech, Healthcare IT and Enterprise Solutions. We have made more than 200 investments and exited more than 170 companies over a history spanning more than 30 years. Edison supports management teams with our industry, investing and operating expertise and access to our Edison Edge platform. We have seen the movie many times before, assist in avoiding pitfalls that are not obvious to less experienced investors, and bring an array of prior successful exits with roadmaps to get there.
New Leaf Venture Partners
New Leaf Venture Partners is an early and growth-stage investor exclusively focused on healthcare technology. We invest across four sectors of healthcare technology: biopharmaceuticals, information convergence, medical devices and life science tools.
In Biopharmaceuticals we invest from seed (creation) stage through to IPO and beyond. We look for large unmet medical needs, strong science, well differentiated technologies, and high-quality pre-clinical and clinical development programs. In Information Convergence (which includes healthcare IT, tools and diagnostics) we invest from early stages through to companies with revenues of $100m+. We have a similar approach in Medical Devices (where we look for important medical devices with the power to reduce costs and improve efficiencies in the healthcare system) and Life Sciences (where we look for products that accelerate the discovery process, uncover novel insights into the biology of disease and health, and personalize diagnoses and treatment).
Greylock Partners
Greylock Partners is one of the world's oldest venture capital firms, having been founded in 1965. Greylock focuses on early-stage companies in software (consumer and enterprise), enterprise infrastructure and semiconductors. We invest at all stages, from Seed through to Series A, B and Growth rounds. We invest in all sectors of enterprise software technology including applications, cloud/SaaS, data center, management, networking, security and storage. We invest in all sectors of consumer software technology including advertising, commerce, gaming, marketplaces, media, mobile, services, and social. Greylock looks for entrepreneurs building market-transforming products and services, and primarily focuses its investing in North America.